#pharmacopoeia impurities suppliers
Explore tagged Tumblr posts
Text
Nicotine USP in Nicotine Replacement Therapy (NRT) A Breakdown
Nicotine Replacement Therapy (NRT) has been a game-changer for smokers seeking to quit and surmount nicotine addiction. Nicotine USP (United States Pharmacopeia) is a key component of nicotine replacement therapy (NRT) products, ensuring safety, purity, and efficacy. This article will examine the significance of Nicotine USP and the options for acquiring it from Nicotine API manufacturers and distributors in the United States and Europe.
Nicotine USP is a pharmaceutical-grade form of nicotine that adheres to rigorous standards of quality and safety. It is an essential component of numerous nicotine replacement therapy (NRT) products, including nicotine gums, patches, lozenges, and inhalers. The USP designation guarantees that the nicotine utilized in these treatments is pure, consistent, and free of impurities.
Nicotine USP procuring: When it comes to procuring Nicotine USP for NRT production, it is crucial to locate dependable suppliers who adhere to regulatory requirements and provide high-quality nicotine. Here are a few
Alternatives to consider: Numerous manufacturers of Nicotine API produce Nicotine USP to pharmaceutical specifications. They provide a primary source of high-quality nicotine to manufacturers of NRT products.
Nicotine USP Vendor in the United States:
Multiple suppliers in the United States specialize in providing Nicotine USP to NRT manufacturers. Frequently, these suppliers adhere to FDA regulations, assuring product safety.
Nicotine USP Supplier in Europe You can also discover reputable Nicotine USP suppliers if you are located in Europe. Typically, these suppliers adhere to European Pharmacopoeia (EP) standards, ensuring the purity and safety of the nicotine they supply.
Crucial Considerations:
When selecting a supplier for Nicotine USP, it is important to consider the following factors:
Ensure that the manufacturer adheres to Good Manufacturing Practices (GMP) to ensure the purity and consistency of Nicotine USP.
Verify that the supplier complies with the applicable pharmaceutical regulations in your region, such as the FDA standards in the United States or the EP standards in Europe.
Documentation and Certification: Seek out suppliers that provide documentation and certification for their Nicotine USP, such as analysis and quality assurance certificates.
Supply Chain Reliability: Evaluate the supplier's capacity to maintain a stable supply chain in order to prevent manufacturing disruptions of your NRT product.
Nicotine USP plays a crucial role in Nicotine Replacement Therapy by providing a safe and regulated form of nicotine to those attempting to cease smoking. It is essential to prioritize quality, safety, and adherence to pharmaceutical standards when sourcing Nicotine USP from Nicotine API manufacturers, suppliers in the United States, or Europe. By doing so, you can contribute to the success of nicotine replacement therapy (NRT) products and assist individuals on their journey to a life without cigarettes.
0 notes
Text
Nicotine USP in Nicotine Replacement Therapy (NRT) A Breakdown
Nicotine Replacement Therapy (NRT) has been a game-changer for smokers seeking to quit and surmount nicotine addiction. Nicotine USP (United States Pharmacopeia) is a key component of nicotine replacement therapy (NRT) products, ensuring safety, purity, and efficacy. This article will examine the significance of Nicotine USP and the options for acquiring it from Nicotine API manufacturers and distributors in the United States and Europe.
Nicotine USP is a pharmaceutical-grade form of nicotine that adheres to rigorous standards of quality and safety. It is an essential component of numerous nicotine replacement therapy (NRT) products, including nicotine gums, patches, lozenges, and inhalers. The USP designation guarantees that the nicotine utilized in these treatments is pure, consistent, and free of impurities.
Nicotine USP procuring: When it comes to procuring Nicotine USP for NRT production, it is crucial to locate dependable suppliers who adhere to regulatory requirements and provide high-quality nicotine. Here are a few
Alternatives to consider: Numerous manufacturers of Nicotine API produce Nicotine USP to pharmaceutical specifications. They provide a primary source of high-quality nicotine to manufacturers of NRT products.
Nicotine USP Vendor in the United States:
Multiple suppliers in the United States specialize in providing Nicotine USP to NRT manufacturers. Frequently, these suppliers adhere to FDA regulations, assuring product safety.
Nicotine USP Supplier in Europe You can also discover reputable Nicotine USP suppliers if you are located in Europe. Typically, these suppliers adhere to European Pharmacopoeia (EP) standards, ensuring the purity and safety of the nicotine they supply.
Crucial Considerations:
When selecting a supplier for Nicotine USP, it is important to consider the following factors:
Ensure that the manufacturer adheres to Good Manufacturing Practices (GMP) to ensure the purity and consistency of Nicotine USP.
Verify that the supplier complies with the applicable pharmaceutical regulations in your region, such as the FDA standards in the United States or the EP standards in Europe.
Documentation and Certification: Seek out suppliers that provide documentation and certification for their Nicotine USP, such as analysis and quality assurance certificates.
Supply Chain Reliability: Evaluate the supplier's capacity to maintain a stable supply chain in order to prevent manufacturing disruptions of your NRT product.
Nicotine USP plays a crucial role in Nicotine Replacement Therapy by providing a safe and regulated form of nicotine to those attempting to cease smoking. It is essential to prioritize quality, safety, and adherence to pharmaceutical standards when sourcing Nicotine USP from Nicotine API manufacturers, suppliers in the United States, or Europe. By doing so, you can contribute to the success of nicotine replacement therapy (NRT) products and assist individuals on their journey to a life without cigarettes.
0 notes
Text
The pharmaceutical industry is building the future of India
The pharma industry is a booming industry with sales and marketing executives working extensively for its widespread. However, a new model will now takeover with a major shift in pharmaceutical industry from mass market to target market methodology in order to augment profits. The future of the pharma industry seems to be very bright in India as it is the third largest pharma industry throughout the world. The Indian pharmaceutical industry is emerging as the best industry to invest in, thru the world and many multinational pharma companies are doing fairly well in India in comparison to other countries worldwide. The industry has low risks with augmented returns and great potential of growth due to which several investors are directed towards the industry.
The government of India has introduced privatization and globalization of the pharma industry which has augmented the growth and with great incentives for development and research in this sector, the industry is gaining new heights. The government also provided several financial policies to the companies in order to carry out research and development. Many other processes were also introduced which will make the future of pharma industry very optimistic. The future of Indian pharmaceutical industry foresees that our country will reach to top 3 positions in the global market by the year 2020 in terms of pharma with awesome growth. Even today, about 20% of generic medicines are exported thru the world from India and the industry has all the potential of growth with skilled workers, technical aptitude and low cost production. With the increase in the number of pharma companies, there is scope for more employment for the populace and thus the future is foreseen as very bright.
In the future the industry will require exhibiting to the patients that their brand is a premium one and will need to offer a complete package with health services and their products in order to get exceptional payments for their brand. The marketing and sales function will change drastically to get higher growth in the future and several changes are expected in the business settings, which will further influence the growth in the pharma sector. The business models which are presently functioning will however not be apt for the year 2020 and more innovation in collaboration is required to acquire desired growth in the sector.
In the future the companies will require amplifying supply chain models for different products for different patients and utilize the chain to differentiate the market. Around 75 percent of renowned companies worldwide are Indian and the future of the companies is very bright. With the development of pharma companies, the economic growth of the country will also augment which will enhance the welfare of the people. With the availability of a large quantity of raw materials and skilled workers India is becoming a hub of manufacturing and research. Cost of manufacturing medicines is around 35-40 percent lower in India as compared to the USA due to low cost of installation and labor. With the introduction of GST in the market, pharma companies are expected to get a major boost as their tax structure is simplified. Major increase in exports and controlling of imports is also strengthening the sector along with several government policies to help in the production and research.
#pharmacopoeia impurities suppliers#chemical industry#pharma industry#pharmaceutical#impurities#pharma sector#india#manufacturing#suppliers
1 note
·
View note
Text
ABACAVIR EP IMPURITY C
ABACAVIR EP IMPURITY C or ABACAVIR USP RC A
CAT No : ALL-ABA-03
Chemical Name : [(1S,4R)-4-(2,6-Diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol
Molecular Formula : C11H14N6O
Molecular Weight : 246.27
CAS Number : 124752-25-6
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : ABACAVIR EP IMPURITY C, ABACAVIR IMPURITY C, ABACAVIR EP IMPURITY C Supplier, ABACAVIR IMPURITY C Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR EP IMPURITY C, ABACAVIR USP RC A. ABACAVIR EP IMPURITY C is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry (or livestock or poultry diseases)
0 notes
Link
Buy gallstones online
oxgallstoneshq
OX-Gallstones-HQ provides Cattle Gallstones Online, Bovine Gallstones Online and OX gallstones in any quantities. Worldwide shipping by air courier (DHL, UPS, TNT).
Buy Gallstones Online at OX-Gallstones-HQ.com. We are export, import and trade with pure high quality natural Gallstones/OXGallstone for pharmaceutical and personal uses.
Our Services:-
We are export, import and trade with pure high quality natural Bovine Gallstones / OXGallstone for pharmaceutical and personal use. We are interested in becoming your regular supplier and ensure consistent supplies of good quality Bovine Gallstones / OXGallstone
We are Hong Kong-based company and we are dealing in Cattle gallstones since 1947, We are Interested in Ox-gallstones and we can buy any quantities any time provided the goods are genuine and prices reasonable. Well dried, golden brown in colour, without bloodstones / black stones/powder. Pls offer available quantities cif Hong Kong
Extracting the gallstones from the Ox, Cow, Cattle’s intestines they have to be washed thoroughly with cold water to remove blood clots, impurities etc. After washing they are dried for two to three weeks in a dark and well ventilated environment at a temperature of approx. 20 degrees Celsius. The stones have to be moved regularly for better drying and to avoid them sticking at each other. After full drying the stones are packed in hermetically sealed bags.
Uses Of OX Gallstones
Ox gallstones are used in the Pharmacopoeia. They are used in medical formulas because of their sedative, anti-inflammatory and antipyretic properties. They are in particular used for treatments of hepatic problems.
Quality Guarantee
Should our product fail to meet your expectations and quality, we'll return your payment to you as soon as possible or make a new order.
· Buy Gallstones
· Buy gallstones online
· Buy cattle gallstones online
· Online cattle gallstones
· Cattle Gallstones For Sale
· Bovine Gallstones online
For more Information
Visit :- https://www.ox-gallstones-hq.com/
0 notes
Link
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of Erythromycin Ethylsuccinate Impurity G. Erythromycin EP Impurity G is an impurity found in Erythromycin and can be used as a reference standard. Erythromycin EP Impurity G is source of Carbohydrates, Nucleosides and Fine Chemicals. Erythromycin EP Impurity G stored in different climatic chambers. We offer the best quality Erythromycin EP Impurity G to our customers at best prices in the industry.
#Erythromycin EP Impurity G#Erythromycin EP Impurity G Supplier#Erythromycin EP Impurity G Manufacturer#Erythromycin Impurity G
0 notes
Text
HealthyEve.com
Ayurveda : Ayurvedic Medicine, Facts And Best Cures For Different Diseases
Sunday,March 26,2017
Originally from India, Ayurveda, or Ayurvedic medicine, is a comprehensive and coherent medical system, as are Western medicine or Traditional Chinese Medicine.
for example. It is considered the oldest medical system in human history. Indian tradition traces its beginnings to 5,000 years, even 10,000 years. However, the writings on which Ayurvedic medical knowledge is based today are less ancient.
The Caraca Samhita was written around 1,500 BC, while the Sushrut Samhita and the Ashtang Hrdyam date from the beginning of the Christian era (between 300 and 500). These 3 texts describe the basic principles of Ayurvedic medicine as it is still practiced in India today.
Although little known in the West, Ayurveda is beginning to attract public interest and its practitioners are in the process of carving out a place among health professionals. The resolutely holistic approach to Ayurvedic medicine probably counts for many in this new infatuation.
It is the patient who is cared for, not his illness. Thus, 3 people with the “same” migraine will be treated in very different ways, according to their constitution, the origin of their evil and the specific characteristics of their migraine.
The Ayurvedic practitioner seeks to heal the person by helping him to regain lost balance, which, according to Ayurveda, is the true cause of the disease. We start from the principle that a being in harmony with his environment, and whose way of life is balanced, will be naturally happy and healthy. It is when this balance is broken that the disease appears.
The practitioner will use a variety of techniques to understand the nature of the person, identify the particular imbalances that cause his illness, and help him regain his natural state of happiness and health.
In Sanskrit, the oldest known structured language, Ayur means “life” and Veda, “knowledge”.
Ayurveda is therefore the science of life, just like biology, which has borrowed in Greek the words bios, “life” and logos, “knowledge”. The Rishis, the enlightened masters who traditionally attributes to the Vedas (the writings that are at the origin of the Hindu religion and Ayurveda), were first and foremost philosophers.
These, like the philosophers of ancient Greece, regarded themselves as Gnostics. They believed that it is possible to attain a state in which one can apprehend, with one’s conscience, the totality of the Universe. This state would allow the body to harmonize with the “ultimate Being”, which would be the safest way to happiness and health.
Ayurveda – Diagnoses in Ayurvedic medicine
For Ayurvedic medicine, the disease results from an imbalance between the doshas. Excess or deficiency of one or the other will cause metabolic disturbance. Ultimately, the disease will appear.
In muscle tissue, for example, an excess of Vata will cause the emaciation of the muscle, a surplus of Pitta will cause infection, while too much of Kapha will cause it to swell. The causes of a disease are therefore to be found in what, in the way of life, habits and environment of the person, caused the imbalance between the doshas.
To explore the causes and various aspects of the disease, the practitioner will first take the pulse of the person. Ayurvedic medicine has pushed this practice to an impressive degree of precision and efficiency, which goes far beyond the number of pulses per minute.
It will also examine the physical characteristics of the patient, the nature of the skin, hair, appetite, condition of eyes, nails, tongue, urine and stool.
Careful study of all these signs will inform him of the nature of the problem that affects the person. An experienced practitioner may even perceive the signs of an imbalance that may cause illness before it manifests itself.
It can then help the person correct the imbalance, preventing the onset of the disease. This preventive aspect is also crucial in Ayurveda. We endeavor to awaken the innate intelligence of the body and the mind, to restore to them their natural faculty to prevent disease, and to maintain joy and serenity.
A situation is created where the disease has no control, to strengthen the body’s natural defenses and to stimulate the processes of elimination of toxins and impurities in order to preserve health.
The treatises of Ayurvedic medicine testify to an astonishing and profound knowledge of the biological, physiological and metabolic processes.
Thus, we find in writings dating back to our era the description of a disease which results from poor nutrition and sedentarism, and which is manifested by the accumulation of a fatty substance on the walls of the blood vessels. This is undoubtedly the oldest description of hypercholesterolemia, its causes, the consequences it entails and the means to be taken to avoid it.
Ayurveda – Treatment strategies in Ayurvedic medicine
To restore lost balance, the Ayurvedic practitioner has a host of techniques to transform the body and mind. He or she can develop a diet adapted to the specific needs of the person, prescribe herbal or aromatherapy preparations, detox treatments, massages, yoga exercises, meditation sessions, in short, a program designed to Change the person’s lifestyle.
The doctor is often seen as a kind of counselor who guides the patient on the path of his recovery. There is even in India a Vedic surgery.
Dietetics occupies a privileged place in Ayurvedic medicine. Each food and medicinal plant is constituted, in variable proportion, of the same elements which form the body and the psyche. The properties thus conferred on foods and plants by the elements that compose them are used to help the person to rebalance his doshas.
For example, green vegetables, raw vegetables, pulses and beef stimulate Vata, while dairy products, nuts, chicken, fish and seafood calm it. The choice, combination and preparation of foods are part of the therapeutic program developed by the practitioner.
Several plants of the Ayurvedic pharmacopoeia have been the subject of scientific studies in India and the West. To realize this, it is enough to consult some of our files that deal with plants commonly used in Ayurveda, such as gum gum, turmeric (see turmeric (psn)), fenugreek, boswellie and gymnastics.
These plants have proven to be effective in treating conditions as diverse as arthritis, hypercholesterolemia, skin diseases, cough, immune system deficiencies, and so on.
However, the Ayurvedic practitioner rarely makes use of only one of these plants at a time. It will instead use complex mixtures, called rasayana, whose overall effect would be synergistic. Researchers at the University of Ohio School of Medicine in the United States have studied one of the best known rasayana, Amrit Kalash, for pharmacological activity.
In vitro and other animal experiments demonstrated that the preparation increased lymphocyte production in the presence of a pathogen or cancer, inhibited platelet aggregation and possessed Powerful antioxidant properties.
According to Dr. Hari Sharma, who presided over all these trials, “it is fascinating to see that modern scientific research demonstrates that this preparation has the effect of strengthening the field, the immune system and the mechanisms of homeostasis, as it is Written in the ancient texts of Ayurveda “.
In the West, the use of these remedies is more a matter of our allopathic pharmacological approach than of the Ayurvedic holistic approach. But interest in the Ayurvedic pharmacopoeia is growing.
Dr. Vladimir Badmaev, Scientific and Medical Director of the Sabinsa Group, a supplier of Ayurvedic plants, believes that “the knowledge accumulated by Ayurveda practitioners over time can help modern medical science discover new and safe medicines ”
Published On
Sunday,March 26,2017-16:29:18[London]
URL: http://www.healthyeve.com/ayurveda-ayurvedic-medicine-facts-best-cures-different-diseases/
You Could Find More About This Article Via Useful Links:
http://www.chopra.com/articles/what-is-ayurveda
http://www.webmd.com/balance/guide/ayurvedic-treatments#1
https://nccih.nih.gov/health/ayurveda/introduction.htm
Related Articles:
http://www.healthyeve.com/sleep-problems-bodies-react-sleep/
http://www.healthyeve.com/gestalt-therapy-top-benefits-effects-mental-health/
http://www.healthyeve.com/optimism-benefits-risks-optimists/
http://www.healthyeve.com/best-tips-boost-immune-system/
http://www.healthyeve.com/arthritis-overview-result-injury-infection/
http://www.healthyeve.com/virtues-fenugreek/
http://www.healthyeve.com/laughter-yoga-therapy-heart-good-shape/
This slideshow requires JavaScript.
Ayurveda : Ayurvedic Medicine, Facts And Best Cures For Different Diseases Ayurveda : Ayurvedic Medicine, Facts And Best Cures For Different Diseases Sunday,March 26,2017 Originally from India, Ayurveda, or Ayurvedic medicine, is a comprehensive and coherent medical system, as are Western medicine or Traditional Chinese Medicine.
0 notes
Text
ABACAVIR USP RC C
ABACAVIR USP RC C Or Abacavir USP Related Compound C
CAT No : ALL-ABA-08
Chemical Name : [(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride
Molecular Formula : C11H13Cl2N5O
Molecular Weight : 302.16
CAS Number : 172015-79-1
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : Abacavir EP Impurity C, Abacavir Impurity C, Abacavir EP Impurity C Supplier, Abacavir EP Impurity C Manufacturer, Abacavir Impurity C Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR USP RC C, ABACAVIR-6-CHLORO ANALOUGE, Abacavir USP Related Compound C. Abacavir EP Impurity C / Abacavir USP Related Compound C is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.
0 notes
Text
ABACAVIR USP RC B
ABACAVIR USP RC B Or Abacavir USP Related Compound B
CAT No : ALL-ABA-07
Chemical Name : [4-(2,5-Diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methano
Molecular Formula : C19H14ClN5O
Molecular Weight : 255.7
CAS Number : 141271-12-7
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : Abacavir EP Impurity B, Abacavir Impurity B, Abacavir EP Impurity B Supplier, Abacavir EP Impurity B Manufacturer, Abacavir Impurity B Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR USP RC B, Abacavir USP Related Compound B. Abacavir EP Impurity B / Abacavir USP Related Compound B is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.
0 notes
Text
Abacavir EP Impurity F
Abacavir EP Impurity F Or O-t-BUTYL DERIVATIVE ABACAVIR (USP)
CAT No : ALL-ABA-06
Chemical Name : 6-(Cyclopropylamino)-9-[(1R,4S)-4-[[(1,1-dimethylethyl)oxy]methyl]cyclopent-2-enyl]-9H-purine-2-amine
Molecular Formula : C18H26N6O
Molecular Weight : 342.44
CAS Number : 1443421-68-8
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : Abacavir EP Impurity F, Abacavir Impurity F, Abacavir EP Impurity F Supplier, Abacavir EP Impurity F Manufacturer, Abacavir Impurity F Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR EP IMPURITY F, O-t-BUTYL DERIVATIVE ABACAVIR (USP), ABACAVIR t-BUTYL ETHER. ABACAVIR EP IMPURITY F is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.
0 notes
Text
ABACAVIR EP IMPURITY E
ABACAVIR EP IMPURITY E Or DIHYDRO ABACAVIR
CAT No : ALL-ABA-05
Chemical Name : [(1R,3S)-3-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopentyl] methanol
Molecular Formula : C14H20N6O
Molecular Weight : 28835
CAS Number : 208762-35-0
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : ABACAVIR EP IMPURITY E, ABACAVIR IMPURITY E, ABACAVIR EP IMPURITY E Supplier, ABACAVIR IMPURITY E Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR EP IMPURITY E Or DIHYDRO ABACAVIR. ABACAVIR EP IMPURITY E is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.
0 notes
Text
ABACAVIR EP IMPURITY D
ABACAVIR EP IMPURITY D or TRANS ABACAVIR
CAT No : ALL-ABA-04
Chemical Name : [(1R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-enyl]methanol dihydrochloride
Molecular Formula : C14H20Cl2N6O
Molecular Weight : 359.25
CAS Number : 783292-37-5 (base) ; 267668-71-3 (HCl salt)
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : ABACAVIR EP IMPURITY D, ABACAVIR IMPURITY D, ABACAVIR EP IMPURITY D Supplier, ABACAVIR IMPURITY D Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR EP IMPURITY D, TRANS ABACAVIR. ABACAVIR EP IMPURITY D is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.
0 notes
Text
ABACAVIR EP IMPURITY B
ABACAVIR EP IMPURITY B or ABACAVIR USP RC D
CAT No : ALL-ABA-02
Chemical Name : 6-(Cyclopropylamino)-9-[(1R,4S)-4-[[(2,5-diamino-6-chloropyrimidin-4-yl)oxy]methyl]cyclopent-2-enyl]-9H-purine-2-amine
Molecular Formula : C18H21ClN10O
Molecular Weight : 428.88
CAS Number : 1443421-69-9
Solubility : Methanol (Slightly), Water (Slightly)
Storage : 2-8 °C
Keywords : ABACAVIR EP IMPURITY B, ABACAVIR IMPURITY B, ABACAVIR EP IMPURITY B Supplier, ABACAVIR IMPURITY B Supplier
Purity by HPLC : NLT - 98%
Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of ABACAVIR EP IMPURITY B, ABACAVIR USP RC D, O-PYRIMIDINE DERIVATIVE ABACAVIR (USP) ABACAVIR EP IMPURITY B is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry (or livestock or poultry diseases). Application - ABACAVIR EP IMPURITY B, ABACAVIR USP RC D, O-PYRIMIDINE DERIVATIVE ABACAVIR (USP), CAS NO - 443421-69-9
0 notes